A Phase 1, Randomized, Open Label, 2-way Crossover Study To Estimate The Effect Of Multiple Dose Pf-06651600 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids In Healthy Female Subjects
Phase of Trial: Phase I
Latest Information Update: 24 Dec 2018
At a glance
- Drugs PF 6651600 (Primary) ; Ethinylestradiol; Levonorgestrel
- Indications Alopecia areata; Crohn's disease; Rheumatoid arthritis; Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Pfizer
- 14 Dec 2018 Status changed from recruiting to completed.
- 12 Nov 2018 Planned End Date changed from 26 Nov 2018 to 23 Nov 2018.
- 02 Oct 2018 Planned End Date changed from 1 Nov 2018 to 26 Nov 2018.